Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10632051rdf:typepubmed:Citationlld:pubmed
pubmed-article:10632051lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:10632051lifeskim:mentionsumls-concept:C0003286lld:lifeskim
pubmed-article:10632051lifeskim:mentionsumls-concept:C0005029lld:lifeskim
pubmed-article:10632051lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:10632051lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:10632051lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:10632051lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:10632051pubmed:issue11lld:pubmed
pubmed-article:10632051pubmed:dateCreated2000-2-14lld:pubmed
pubmed-article:10632051pubmed:abstractTextA comparison of enaminones from various unsubstituted and p-substituted benzamides to the analogous benzylamines has been undertaken with the aim of elucidating the essential structural parameters necessary for anticonvulsant activity. Initial studies on methyl 4-N-(benzylamino)-6-methyl-2-oxocyclohex-3-en-1-oate, 3a, 3-N-(benzylamino)cyclohex-2-en-1-one, 3p, and 5,5-dimethyl-3-N-(benzylamino)-cyclohex-2-en-1-one, 3r indicated that benzylamines possessed significant anti-maximal electroshock seizure (MES) activity. Evaluation of the analogous benzamides revealed significant differences in anticonvulsant activity, these differences were most probably related to the differences in their three-dimensional structures.lld:pubmed
pubmed-article:10632051pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10632051pubmed:languageenglld:pubmed
pubmed-article:10632051pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10632051pubmed:citationSubsetIMlld:pubmed
pubmed-article:10632051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10632051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10632051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10632051pubmed:statusMEDLINElld:pubmed
pubmed-article:10632051pubmed:monthNovlld:pubmed
pubmed-article:10632051pubmed:issn0968-0896lld:pubmed
pubmed-article:10632051pubmed:authorpubmed-author:SmithC ACAlld:pubmed
pubmed-article:10632051pubmed:authorpubmed-author:NicholsonJ...lld:pubmed
pubmed-article:10632051pubmed:authorpubmed-author:ButcherRRlld:pubmed
pubmed-article:10632051pubmed:authorpubmed-author:ScottK RKRlld:pubmed
pubmed-article:10632051pubmed:authorpubmed-author:HensonM CMClld:pubmed
pubmed-article:10632051pubmed:authorpubmed-author:EdafioghoI...lld:pubmed
pubmed-article:10632051pubmed:authorpubmed-author:FosterJ EJElld:pubmed
pubmed-article:10632051pubmed:authorpubmed-author:GoodwinA MAMlld:pubmed
pubmed-article:10632051pubmed:authorpubmed-author:StablesJ PJPlld:pubmed
pubmed-article:10632051pubmed:issnTypePrintlld:pubmed
pubmed-article:10632051pubmed:volume7lld:pubmed
pubmed-article:10632051pubmed:ownerNLMlld:pubmed
pubmed-article:10632051pubmed:authorsCompleteYlld:pubmed
pubmed-article:10632051pubmed:pagination2415-25lld:pubmed
pubmed-article:10632051pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:10632051pubmed:meshHeadingpubmed-meshheading:10632051...lld:pubmed
pubmed-article:10632051pubmed:meshHeadingpubmed-meshheading:10632051...lld:pubmed
pubmed-article:10632051pubmed:meshHeadingpubmed-meshheading:10632051...lld:pubmed
pubmed-article:10632051pubmed:meshHeadingpubmed-meshheading:10632051...lld:pubmed
pubmed-article:10632051pubmed:meshHeadingpubmed-meshheading:10632051...lld:pubmed
pubmed-article:10632051pubmed:meshHeadingpubmed-meshheading:10632051...lld:pubmed
pubmed-article:10632051pubmed:meshHeadingpubmed-meshheading:10632051...lld:pubmed
pubmed-article:10632051pubmed:meshHeadingpubmed-meshheading:10632051...lld:pubmed
pubmed-article:10632051pubmed:meshHeadingpubmed-meshheading:10632051...lld:pubmed
pubmed-article:10632051pubmed:meshHeadingpubmed-meshheading:10632051...lld:pubmed
pubmed-article:10632051pubmed:meshHeadingpubmed-meshheading:10632051...lld:pubmed
pubmed-article:10632051pubmed:meshHeadingpubmed-meshheading:10632051...lld:pubmed
pubmed-article:10632051pubmed:meshHeadingpubmed-meshheading:10632051...lld:pubmed
pubmed-article:10632051pubmed:year1999lld:pubmed
pubmed-article:10632051pubmed:articleTitleSynthesis, characterization and anticonvulsant activity of enaminones. Part 6: Synthesis of substituted vinylic benzamides as potential anticonvulsants.lld:pubmed
pubmed-article:10632051pubmed:affiliationDepartment of Chemistry, Graduate School of Arts and Sciences, Howard University, Washington, DC 20059, USA.lld:pubmed
pubmed-article:10632051pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10632051pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:10632051pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed